AIM: To describe the prevalence, correlates of, and reasons for use of roll-your-own (RYO) tobacco in a high RYO use and ethnically diverse country: New Zealand (NZ). METHODS: The NZ arm of the International Tobacco Control Policy Evaluation Survey (ITC Project) is sampled from the New Zealand Health Survey, with boosted sampling of Māori, Pacific peoples, and Asian New Zealanders. We surveyed 1,376 current adult smokers using standard ITC project procedures in 2007-2008. RESULTS: Prevalence of regularly smoking RYOs was 53% (with 38% of all smokers being exclusive RYO smokers). RYO use was higher among disadvantaged smokers, heavier smokers, those with a relatively low intention of quitting, and those with more friends who smoke. RYO use increased more in the youngest age groups as disadvantage increased. "Lower price" dominated the reasons smokers' cited for smoking RYOs (at 83%). About one fifth cited "less health concerns" as a reason. CONCLUSIONS: RYO smoking is particularly associated with individual deprivation and high levels of dependence. Its capacity to blunt price signals provided by tobacco taxes is accompanied by misperceptions that it is less hazardous to health and it is particularly prevalent among vulnerable disadvantaged populations (including Māori, young people, and those with mental health problems). Governments should reconsider removing any tax advantages given to RYO tobacco, ensure RYO smokers are properly informed of health risks, and supported to quit as strongly as other smokers. However, governments should also examine a broader range of options including a higher differential tax on RYO tobacco, removing flavors, and controlling all tobacco marketing.
AIM: To describe the prevalence, correlates of, and reasons for use of roll-your-own (RYO) tobacco in a high RYO use and ethnically diverse country: New Zealand (NZ). METHODS: The NZ arm of the International Tobacco Control Policy Evaluation Survey (ITC Project) is sampled from the New Zealand Health Survey, with boosted sampling of Māori, Pacific peoples, and Asian New Zealanders. We surveyed 1,376 current adult smokers using standard ITC project procedures in 2007-2008. RESULTS: Prevalence of regularly smoking RYOs was 53% (with 38% of all smokers being exclusive RYO smokers). RYO use was higher among disadvantaged smokers, heavier smokers, those with a relatively low intention of quitting, and those with more friends who smoke. RYO use increased more in the youngest age groups as disadvantage increased. "Lower price" dominated the reasons smokers' cited for smoking RYOs (at 83%). About one fifth cited "less health concerns" as a reason. CONCLUSIONS:RYO smoking is particularly associated with individual deprivation and high levels of dependence. Its capacity to blunt price signals provided by tobacco taxes is accompanied by misperceptions that it is less hazardous to health and it is particularly prevalent among vulnerable disadvantaged populations (including Māori, young people, and those with mental health problems). Governments should reconsider removing any tax advantages given to RYOtobacco, ensure RYO smokers are properly informed of health risks, and supported to quit as strongly as other smokers. However, governments should also examine a broader range of options including a higher differential tax on RYOtobacco, removing flavors, and controlling all tobacco marketing.
Authors: Valentina Minardi; Gianluigi Ferrante; Paolo D'Argenio; Maria Masocco; Lorenzo Spizzichino; Carla Bietta; Benedetta Contoli; Silvano Gallus Journal: Int J Public Health Date: 2019-01-25 Impact factor: 3.380
Authors: Ramzi G Salloum; Fastone Goma; Grieve Chelwa; Xi Cheng; Richard Zulu; Susan C Kaai; Anne C K Quah; James F Thrasher; Geoffrey T Fong Journal: Tob Control Date: 2015-01-28 Impact factor: 7.552
Authors: Zachary R Rosenberry; Andrew A Strasser; Lauren L Canlas; Jennifer L Potts; Wallace B Pickworth Journal: Nicotine Tob Res Date: 2013-01-07 Impact factor: 4.244
Authors: Bartosz Koszowski; Zachary R Rosenberry; Lauren C Viray; Jennifer L Potts; Wallace B Pickworth Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-06-12 Impact factor: 4.254
Authors: Filippos T Filippidis; Pete Driezen; Christina N Kyriakos; Paraskevi Katsaounou; Ioanna Petroulia; Charis Girvalaki; Marcela Fu; Esteve Fernández; Ute Mons; Antigona C Trofor; Tibor Demjén; Krzysztof Przewoźniak; Witold A Zatoński; Geoffrey T Fong; Yannis Tountas; Constantine I Vardavas Journal: Eur J Public Health Date: 2020-07-01 Impact factor: 3.367
Authors: J Robert Branston; Ann McNeill; Anna B Gilmore; Rosemary Hiscock; Timea R Partos Journal: Drug Alcohol Depend Date: 2018-10-06 Impact factor: 4.492
Authors: Silvano Gallus; Alessandra Lugo; Simone Ghislandi; Carlo La Vecchia; Anna B Gilmore Journal: Eur J Cancer Prev Date: 2014-05 Impact factor: 2.497